(From left to right, from top to bottom are Professor, Professor, Professor Yang, Professor Qi Hongbo, Professor Chen Dunjin and Professor Jing He)
The conference featured interdisciplinary themes and was based on clinical practice, aiming at solving practical problems. This paper focuses on the latest hot and difficult issues, new methods, new guidelines and new techniques in obstetrics clinic at home and abroad, as well as first aid in delivery room, management, key techniques of midwifery and difficult obstetric operations, and makes a wonderful keynote speech. The meeting also arranged special training on obstetric techniques, which attracted the active participation of more than 2,000 obstetricians and gynecologists.
opening ceremony
At 8 o'clock in the morning, under the auspices of Professor Liu Xinghui, the opening ceremony officially began. First of all, Liu Jiaoshou thanked all the distinguished guests and doctors for coming. Huaxi Forum has gone through 12 years, and each session has gathered academic experts from obstetrics and interdisciplinary to bring you the latest information and interpretation at home and abroad. With your support, Huaxi Forum has become a famous professional activity at home and abroad. I wish you all something at this meeting. Later, the guests also took the stage to deliver speeches and wished the conference a complete success.
The main speech delivered at the meeting
Several key updates of the ninth edition textbook. Professor Duan Tao from Shanghai No.1 Maternal and Infant Health Hospital.
This textbook is based on authoritative guides such as ACOG guide, William guide and domestic guide, and has been revised according to the national conditions of China. Hypertensive disorder complicating pregnancy (PIH) has changed a lot, so to avoid ambiguity, the classification is more clear. Whether there are severe manifestations of preeclampsia, but the expression of severity has not been deleted; Urine protein is no longer a necessary standard; Regarding the classification of hypertension, there is no mention of mild, moderate and severe, but the treatment is guided by this; Standardize the treatment of magnesium sulfate; Put forward different suggestions according to the degree of hypertension; Revise the prevention plan according to the NEJM RCT study. In addition, the diagnosis and international unification of cervical incompetence; Change the pathological classification and grading of placental abruption to make it more scientific and accurate. Placenta implantation is set as the basis for doctors' clinical treatment, so that everyone can understand the definition and simple principle.
Guidelines for diagnosis and treatment of thyroid diseases during pregnancy-revised points? Professor Teng Weiping from the First Affiliated Hospital of China Medical University.
Endocrinology and Hematology Branch of Chinese Medical Association communicated with experts of perinatal medical association for many times, and revised the pregnancy guideline of China on the basis of 20 12 guideline. The new guide revised the reference value of TSH. If the specific reference range of TSH in pregnant population cannot be obtained, the upper limit of the reference range of non-pregnant population can be reduced by 20%, or 4.0mU/L can be used as the tangent value of TSH in early pregnancy. For the indicators of subclinical hypothyroidism, according to the contents of the guidelines, there is insufficient evidence that L-T4 intervenes in simple hypothyroidism to improve the adverse pregnancy outcome and the impairment of neurointellectual development of offspring, but in view of the safety of low-dose L-T4 application, L-T4 treatment can be considered in the early pregnancy. During 6- 10 weeks of pregnancy, antithyroid drugs should be stopped to avoid congenital malformation, and the negative effects of iodine excess should be paid attention to in iodine supplementation.
Obstetric challenges? Professor Yang from the First Hospital of Peking University
After entering the post-cesarean section era, obstetricians and gynecologists are facing more and more challenges. It is necessary to improve the ability to treat critically ill patients, reduce maternal and infant mortality, change from treatment to early intervention of high-risk factors, and practice the preventive concept of "preventing diseases before they occur". Paying attention to perinatal health care is very important for the health of mother and baby all their lives, so doctors should learn to identify high-risk groups, implement early intervention and implement a multidisciplinary consultation system centered on obstetric rescue. For diseases that cannot be prevented, such as amniotic fluid embolism, there is not much experience to test, so we must practice more at ordinary times and try our best to ensure that there are no regrets during the treatment. However, the health care mode of obstetrics has changed to early assessment, intervention or graded diagnosis and treatment of mother and baby, so as to minimize the occurrence of complications.
Postpartum hemorrhage, twenty years in China? Professor Liu Xinghui from West China Second Hospital of Sichuan University
Although China has achieved the Millennium Development Goal of reducing the maternal mortality rate of postpartum hemorrhage by 80% ahead of schedule, obstetricians still face challenges such as elderly women, scarred uterus, uterine rupture, dangerous placenta previa and the two-child policy. At present, the second edition of Guidelines for Postpartum Hemorrhage (20 14) revised in China has been continuously improved in the definition of hemorrhage, the prevention of hemorrhage, and the management of blood transfusion and infusion for severe hemorrhage. Postpartum hemorrhage should be treated in a standardized way, and the principles of early breathing, early resuscitation, early evaluation and early hemostasis should be followed in rescuing hemorrhage. In addition to training doctors at the grass-roots level and educating patients, it is also necessary to design personalized treatment plans according to the situation of hospitals and patients, follow the principle of teamwork, take diversified hemostasis measures, and transfuse blood and its products as soon as possible.
Influence of iron deficiency during pregnancy on mother and infant and research progress of perinatal iron supplementation scheme? Professor Wang Xietong from Shandong Provincial Hospital
First of all, I would like to thank Dr. Hongyuan for his contribution in strengthening doctors' attention to iron supplementation and the treatment of iron deficiency anemia in China. Although the prevalence of anemia in pregnancy in China is slightly lower than the global data, IDA screening and iron supplementation in China are not standardized, which urgently needs doctors' attention. Iron deficiency is closely related to the adverse pregnancy outcome of mother and infant. Studies have shown that iron deficiency may be an important risk factor for maternal depression. Iron deficiency during pregnancy will aggravate the occurrence of premature delivery and affect the intelligence, sports, hearing and long-term cognitive development of infants. The nutritional status of vitamins and minerals in pregnant women in China is not optimistic. Because the intake of iron in food is far from meeting the daily iron requirement, and the loss of iron during pregnancy is huge, the main treatment for iron deficiency anemia is still oral iron. Iron deficiency is common during pregnancy, so it is recommended to supplement iron from the week of pregnancy 16 to the third month after delivery. Among the oral iron preparations on the market at present, Hongyuanda (polysaccharide-iron complex) is the oral iron preparation with the highest content of elemental iron at present, and has few side effects, so it is recommended by authoritative reading materials such as "Guidelines for diagnosis and treatment of iron deficiency anemia during pregnancy" and obstetrics and gynecology textbooks.
Qingdao Guofeng Pharmaceutical Co., Ltd., Shanghai Pharmaceutical Group, attached great importance to this grand event and actively cooperated and supported it. Sponsor the conference information kit and support hundreds of doctors to participate in the forum. During the forum, the corporate culture and academic spirit of Shanghai Pharmaceutical Co., Ltd. were fully displayed, which won unanimous praise from the organizers, experts and doctors attending the meeting, and the company's product Hongyuanda (polysaccharide-iron complex capsule) was also unanimously recognized by the experts attending the meeting.
(The conference information package is provided by Shangyao Guofeng)
(Shangyao Guofeng Hongyuanda booth)
(The pictures in this article are collected from the Internet)